相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology
Aleksandra Klimas et al.
NATURE COMMUNICATIONS (2016)
Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging
Graham T. Dempsey et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm
Bernard Fermini et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Action Potential Morphology of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Does Not Predict Cardiac Chamber Specificity and Is Dependent on Cell Density
David T. M. Du et al.
BIOPHYSICAL JOURNAL (2015)
High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds
Hua Rong Lu et al.
TOXICOLOGICAL SCIENCES (2015)
Comprehensive T wave Morphology Assessment in a Randomized Clinical Study of Dofetilide, Quinidine, Ranolazine, and Verapamil
Jose Vicente et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2015)
Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
Philip T. Sager et al.
AMERICAN HEART JOURNAL (2014)
Action Potential Characterization of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using Automated Patch-Clamp Technology
Olaf Scheel et al.
ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES (2014)
Computational Models of Ventricular- and Atrial-Like Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
Michelangelo Paci et al.
ANNALS OF BIOMEDICAL ENGINEERING (2013)
Electronic expression of the inward rectifier in cardiocytes derived from human-induced pluripotent stem cells
Glenna C. L. Bett et al.
HEART RHYTHM (2013)
Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models
Udo Kraushaar et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Application of human stem cell-derived cardiomyocytes in safety pharmacology requires caution beyond hERG
Malin K. B. Jonsson et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Cardiac safety pharmacology: from human ether-a-gogo related gene channel block towards induced pluripotent stem cell based disease models
Udo Kraushaar et al.
EXPERT OPINION ON DRUG SAFETY (2012)
High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents
Junyi Ma et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)
Class I/B antiarrhythmic property of ranolazine, a novel antianginal agent, in dog and human cardiac preparations
Tamas Szel et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Electrophysiological Characterization of Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells
Masaki Honda et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2011)
Simulation of the Undiseased Human Cardiac Ventricular Action Potential: Model Formulation and Experimental Validation
Thomas O'Hara et al.
PLOS COMPUTATIONAL BIOLOGY (2011)
Re-Evaluation of the Action Potential Upstroke Velocity as a Measure of the Na+ Current in Cardiac Myocytes at Physiological Conditions
Geza Berecki et al.
PLOS ONE (2010)
Quantified proarrhythmic potential of selected human embryonic stem cell-derived cardiomyocytes
Malin K. B. Jonsson et al.
STEM CELL RESEARCH (2010)
The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes
Shengde Peng et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2010)
Use-dependent block of cardiac late Na+ current by ranolazine
Sridharan Rajamani et al.
HEART RHYTHM (2009)
Beat-to-beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes
Morten B. Thomsen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Antagonism by ranolazine of the pro-arrhythmic effects of increasing late INa in guinea pig ventricular myocytes
YJ Song et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2004)
Ranolazine:: Ion-channel-blocking actions and in vivo electrophysiological effects
G Schram et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development
WS Redfern et al.
CARDIOVASCULAR RESEARCH (2003)
分享论文
